SLC5A2 and type 2 diabetes mellitus: To this end, archival tissue specimens from 5 healthy individuals, 6 individuals with T2D not treated with SGLT2 inhibitors (T2D+SGLT2i–) and 7 individuals with T2D treated with SGLT2 inhibitors (T2D+SGLT2i+) from a previous study46 were selected for analysis.